DURHAM, NC, UNITED STATES, August 25, 2026 /EINPresswire.com/ — Drummond Group, LLC, a trusted leader in health IT certification and interoperability testing, released the FHIRplace Q2 2026 Testing Report, showcasing how structured FHIR-based testing identifies real-world interoperability challenges and enables organizations to resolve them before deployment.

Q2 2026 testing focused on Coverage Requirements Discovery (CRD), a critical prior authorization workflow component that enables payers and providers to exchange real-time coverage information before clinical decisions.

During Q2 2026, FHIRplace participants executed structured FHIR testing across coverage data exchange workflows. The testing identified interoperability issues for remediation and achieved an 89% success rate on executed test scenarios. This outcome demonstrates that multi-party testing of data exchange workflows enables health IT developers, payers, providers, and intermediaries to validate interoperability before deployment, reducing integration friction and accelerating market readiness.

To ensure that real-world testing rigor translates into actionable fixes, Drummond has introduced an Issue Typology Metrics framework and reporting methodology that standardizes how interoperability problems are classified, tracked, and resolved. This rigor gives participants and the market clear visibility into what was tested, what failed, and how remediation progressed. FHIRplace recognizes two levels of participation. The FHIRplace Participant emblem marks organizations actively engaged in structured FHIR testing. The Drummond Validated seal is awarded to organizations that successfully demonstrate interoperability across the multi-party testing matrix.

“When organizations complete FHIRplace testing and achieve the Drummond Validated seal, they’re not just earning a credential. They’ve proven in real-world multi-party conditions that their systems work before go-live. That’s the evidence that separates market leaders from the rest,” said Timothy Bennett, Director of Strategic Healthcare Initiatives at Drummond Group.

Q2 2026 CRD testing participants and their products included Medplum (Medplum), Nucural (Affosoft Inc.), MEDITECH (MEDITECH Expanse), Firely (Firely PAROD), ZeOmega (HealthUnity Smart Authorization Gateway), Smile Digital Health (Smile CDR Inc.), and Itiliti Health (PA Checkpoint). Organizations interested in participating in FHIRplace receive structured test plans and test against a multi-party testing matrix, helping them identify and resolve interoperability issues faster. The Q2 2026 Testing Report is available here: FHIRplace-Program-Testing-Report-Q2-2026-72926.pdf

About Drummond

Founded in 1999, Drummond is an independent firm providing compliance and conformance testing and certification, as well as security assessment services to regulated industries. Drummond’s expert-led assessments serve organizations across healthcare, financial services, life sciences, retail, technology, and manufacturing, providing the independent verification their markets and regulators require. With deep experience in complex regulatory frameworks and interoperability, Drummond helps clients navigate evolving requirements confidently and efficiently. Learn more at https://www.drummondgroup.com/

Lucy Railton
Drummond Group, LLC
+1 877-437-8666
email us here

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author
Written By: EIN Presswire